Apple's shares were down about 3% at $480.50 before the market opened, a day after it unveiled the 5S, a high-end iPhone with a fingerprint scanner as well as a cheaper 5C model targeted at emerging markets.
"...We worry that Apple's inability/unwillingness to come out with a low-priced offering for emerging markets nearly ensures that the company will continue to be an overall share loser in the smartphone market until it choses to address the low end," Sanford Bernstein analysts said in a note.
Still, Bernstein maintained its "outperform" rating on Apple's stock, saying that it expected the new iPhones to have little impact on gross margins.
Nomura Equity Research analyst Stuart Jeffrey, who raised his price target for Apple shares to $480 from $420, said Apple may have ensured stable margins for the next couple of quarters by pricing the 5C at $99 with a contract and $549 without.
This was not enough for BofA Merrill Lynch and Credit Suisse. Both downgraded Apple's stock to "neutral" from "buy" and "outperform."
"Rather than offer attractive pricing for consumers, and move the iPhone 5c into a new and growing price segment, Apple retained a premium pricing strategy in targeting the $400-800 smartphone segment," Credit Suisse analyst Kulbinder Garcha said in a note.
"This segment is not forecast to see meaningful growth long term. This decision, at the margin, is good for profitability but not growth."
Garcha said that Apple's share of the smartphone market, where it faces intense competition from Samsung Electronics, would likely fall to 15.5% this year and 13.1 next year from 18.1% last year.
Saying the 5C was "nobody's low-margin phone", Cowen and Company analyst Timothy Arcuri said Apple's new relationships with Japan's NTT DoCoMo Inc and China Mobile Ltd supported the view that 2014 Street estimates for Apple earnings looked too low.
Arcuri said gross margins for the 5C appeared to be as high as the mid-50% area.
Apple's third-quarter profit fell 22% as gross margins slid below 37% from more than 42% in the year-earlier quarter.
"While the 5C is a first step away from the high-end, we do not think it is a big one," JP Morgan's Mark Moskowitz said.
The 5C will sell for 4,488 yuan ($730) China, almost $200 more than in the United States.
Canaccord Genuity kept its "buy" rating on the stock and raised the target price to $550 from $530, citing Apple's aggressive launch plans in more than 100 countries by year-end.
Canaccord also raised its 2014 estimate for iPhone sales to 180 million phones from 177 million.
Lazard Capital Markets raised its share price target to $570 from $500, noting a "best in class user experience".
"With escalating investor focus on Apple's diminishing product differentiation, slowing growth and margin compression, we think it's time to revisit what makes Apple unique," Lazard analyst Edward Parker wrote in a note.
"...We propose that Apple is a 'storage' company, not only levered to data creation but instrumental in driving data creation in ways its competitors are not," he said.
Anda sedang membaca artikel tentang
Apple's new iPhones: Analysts's take
Dengan url
http://pijitsehat.blogspot.com/2013/09/apples-new-iphones-analystss-take.html
Anda boleh menyebar luaskannya atau mengcopy paste-nya
Apple's new iPhones: Analysts's take
namun jangan lupa untuk meletakkan link
Apple's new iPhones: Analysts's take
sebagai sumbernya
0 komentar:
Posting Komentar